Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.8117
+0.0003 (0.04%)
Feb 24, 2026, 11:53 AM EST - Market open
Evogene Revenue
Evogene had revenue of $312.00K in the quarter ending September 30, 2025, a decrease of -82.63%. This brings the company's revenue in the last twelve months to $5.25M, down -26.75% year-over-year. In the year 2024, Evogene had annual revenue of $8.51M with 50.90% growth.
Revenue (ttm)
$5.25M
Revenue Growth
-26.75%
P/S Ratio
0.91
Revenue / Employee
$68,513
Employees
117
Market Cap
7.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.51M | 2.87M | 50.90% |
| Dec 31, 2023 | 5.64M | 3.97M | 236.72% |
| Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
| Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
| Dec 31, 2020 | 1.04M | 287.00K | 38.11% |
| Dec 31, 2019 | 753.00K | -994.00K | -56.90% |
| Dec 31, 2018 | 1.75M | -1.63M | -48.33% |
| Dec 31, 2017 | 3.38M | -3.16M | -48.30% |
| Dec 31, 2016 | 6.54M | -4.59M | -41.23% |
| Dec 31, 2015 | 11.13M | -3.38M | -23.31% |
| Dec 31, 2014 | 14.51M | -3.07M | -17.46% |
| Dec 31, 2013 | 17.58M | 509.00K | 2.98% |
| Dec 31, 2012 | 17.07M | 2.17M | 14.57% |
| Dec 31, 2011 | 14.90M | 2.34M | 18.61% |
| Dec 31, 2010 | 12.56M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEVGN News
- 5 days ago - Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release - PRNewsWire
- 7 days ago - Evogene (EVGN) Partners with QUT to Combat Lung Cancer Drug Resistance - GuruFocus
- 7 days ago - Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics - PRNewsWire
- 13 days ago - Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases - PRNewsWire
- 13 days ago - Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds - PRNewsWire
- 14 days ago - Evogene (EVGN) Expands Collaboration with Google Cloud to Boost AI Capabilities - GuruFocus
- 14 days ago - Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™ - PRNewsWire
- 15 days ago - Evogene Appoints Prof. John Irwin and Prof. - PRNewsWire